Search Results
AdAlta i-body Platform Briefing - Sam Cobb - AD-114 Update
AdAlta i-body Platform Briefing - Highlights
AdAlta fibrosis briefing: Sam Cobb, CEO AdAlta Limited
AdAlta i-body Platform Briefing - Mick Foley - G-Protein Coupled Receptors
AdAlta i-body Platform Briefing - Panel Discussion
AdAlta MD & CEO Sam Cobb | The i-body & lung fibrosis
AdAlta i-body Platform Briefing - Carol Pollock - Ion Channels
AdAlta (ASX:1AD) CEO Sam Cobb - Investival Showcase 2018
AdAlta i-body Platform Briefing - Bianca Ogden - Drug Discovery Landscape
AdAlta Limited: Fibrosis briefing highlights February 2017
AdAlta (ASX: 1AD): Sam Cobb, Managing Director and CEO
AdAlta (ASX: 1AD): Sam Cobb, Managing Director & Chief Executive Officer
